Liu Fengliang, Fan Xiuzhen, Auclair Sarah, Ferguson Monique, Sun Jiaren, Soong Lynn, Hou Wei, Redfield Robert R, Birx Deborah L, Ratto-Kim Silvia, Robb Merlin L, Kim Jerome H, Michael Nelson L, Hu Haitao
Department of Microbiology & Immunology and Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, Texas, United States of America.
Division of Infectious Diseases, University of Texas Medical Branch, Galveston, Texas, United States of America.
PLoS Pathog. 2016 Jun 9;12(6):e1005663. doi: 10.1371/journal.ppat.1005663. eCollection 2016 Jun.
Loss of immune control over opportunistic infections can occur at different stages of HIV-1 (HIV) disease, among which mucosal candidiasis caused by the fungal pathogen Candida albicans (C. albicans) is one of the early and common manifestations in HIV-infected human subjects. The underlying immunological basis is not well defined. We have previously shown that compared to cytomegalovirus (CMV)-specific CD4 cells, C. albicans-specific CD4 T cells are highly permissive to HIV in vitro. Here, based on an antiretroviral treatment (ART) naïve HIV infection cohort (RV21), we investigated longitudinally the impact of HIV on C. albicans- and CMV-specific CD4 T-cell immunity in vivo. We found a sequential dysfunction and preferential depletion for C. albicans-specific CD4 T cell response during progressive HIV infection. Compared to Th1 (IFN-γ, MIP-1β) functional subsets, the Th17 functional subsets (IL-17, IL-22) of C. albicans-specific CD4 T cells were more permissive to HIV in vitro and impaired earlier in HIV-infected subjects. Infection history analysis showed that C. albicans-specific CD4 T cells were more susceptible to HIV in vivo, harboring modestly but significantly higher levels of HIV DNA, than CMV-specific CD4 T cells. Longitudinal analysis of HIV-infected individuals with ongoing CD4 depletion demonstrated that C. albicans-specific CD4 T-cell response was preferentially and progressively depleted. Taken together, these data suggest a potential mechanism for earlier loss of immune control over mucosal candidiasis in HIV-infected patients and provide new insights into pathogen-specific immune failure in AIDS pathogenesis.
在HIV-1(HIV)疾病的不同阶段,对机会性感染的免疫控制可能会丧失,其中由真菌病原体白色念珠菌(白色念珠菌)引起的黏膜念珠菌病是HIV感染人类受试者早期常见的表现之一。其潜在的免疫基础尚不明确。我们之前已经表明,与巨细胞病毒(CMV)特异性CD4细胞相比,白色念珠菌特异性CD4 T细胞在体外对HIV高度易感。在此,基于一个未经抗逆转录病毒治疗(ART)的HIV感染队列(RV21),我们纵向研究了HIV对体内白色念珠菌和CMV特异性CD4 T细胞免疫的影响。我们发现在进行性HIV感染期间,白色念珠菌特异性CD4 T细胞反应存在顺序性功能障碍和优先耗竭。与Th1(IFN-γ、MIP-1β)功能亚群相比,白色念珠菌特异性CD4 T细胞的Th17功能亚群(IL-17、IL-22)在体外对HIV更易感,并且在HIV感染受试者中更早受损。感染史分析表明,在体内,白色念珠菌特异性CD4 T细胞比CMV特异性CD4 T细胞更容易感染HIV,其HIV DNA水平虽适度但显著更高。对持续CD4细胞耗竭的HIV感染者进行纵向分析表明,白色念珠菌特异性CD4 T细胞反应优先且逐渐耗竭。综上所述,这些数据提示了HIV感染患者对黏膜念珠菌病免疫控制早期丧失的潜在机制,并为艾滋病发病机制中病原体特异性免疫衰竭提供了新的见解。